As­traZeneca and Glax­o­SmithK­line come to a peace­ful set­tle­ment of their tug of war over Luke Miels

It looks like Luke Miels “gar­den­ing leave” will run through the sum­mer be­fore he bids one fi­nal farewell to As­traZeneca and moves over to Glax­o­SmithK­line as phar­ma chief.

The two UK phar­ma gi­ants qui­et­ly duked it out over Miels af­ter Glax­o­SmithK­line an­nounced the move. As­traZeneca boxed him up with his con­tract, su­ing him over the move, but GSK says to­day that Miels will now start his new job — free of any old strings — as phar­ma pres­i­dent on Sep­tem­ber 4.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER